Tag: Coherus BioSciences

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Coherus BioSciences

Maxim Group Reiterates $18.00 Price Target for Coherus BioSciences (NASDAQ:CHRS)

Added to Collection on: 2018-05-29 07:48:45

Tags for this article:

Money
Finance
Economy
NASDAQ
Stock
Price?earnings ratio
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
Coherus Biosciences (CHRS) Lowered to Hold at BidaskClub

Added to Collection on: 2018-05-31 18:41:15

Tags for this article:

Money
Finance
NASDAQ
Stock market
Stock
Financial markets
Corporate finance
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
Coherus Biosciences (CHRS) Now Covered by HC Wainwright

Added to Collection on: 2018-09-04 18:07:30

Tags for this article:

Finance
Stock market
Stock
Financial economics
Financial markets
Short
Corporate finance
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
HC Wainwright Reaffirms Buy Rating for La Jolla Pharmaceutical (NASDAQ:LJPC)

Added to Collection on: 2018-09-16 00:18:45

Tags for this article:

Health
Health care
Gene therapy
Cellectis
Coherus BioSciences
Editas Medicine
Companies
Audentes Therapeutics
Momenta Pharmaceuticals
Sangamo Therapeutics
Iovance Biotherapeutics
Atara Biotherapeutics
aUTOLUS THERAPEUTICS
DENALI THERAPEUTICS
Solid Biosciences
RUBIUS THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Zacks: Brokerages Anticipate La Jolla Pharmaceutical (LJPC) Will Post Quarterly Sales of $3.38 ...

Added to Collection on: 2018-09-15 23:11:15

Tags for this article:

Health
Health care
Gene therapy
Cellectis
Coherus BioSciences
Editas Medicine
Companies
Audentes Therapeutics
Momenta Pharmaceuticals
Sangamo Therapeutics
Iovance Biotherapeutics
Atara Biotherapeutics
aUTOLUS THERAPEUTICS
DENALI THERAPEUTICS
Solid Biosciences
RUBIUS THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details
Coherus BioSciences (NASDAQ:CHRS) Rating Increased to Hold at BidaskClub

Added to Collection on: 2021-01-09 06:48:26

Tags for this article:

Finance
Financial markets
Money
Equity securities
Corporate finance
Financial ratios
Stock
Price?earnings ratio
Short
Financial analyst
Share
Dividend
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
Shifting strategy, Coherus buys rights to experimental cancer drug

Added to Collection on: 2021-02-01 17:14:31

Tags for this article:

Drugs
Health sciences
Health care
Monoclonal antibodies
Bristol-Myers Squibb
Novartis
Bristol-Myers Squibb
BeiGene
Merck & Co.
Amgen
Nivolumab
Adalimumab
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
HC Wainwright Lowers Coherus BioSciences (NASDAQ:CHRS) Price Target to $26.00

Added to Collection on: 2021-05-07 10:18:45

Tags for this article:

Finance
Money
Economy
Stock market
Corporate finance
Occupations
Securities research
Stock
UBS
Price?earnings ratio
Short
Coherus BioSciences
HC Wainwright

Click the tags to see associated articles and topics

View Article Details
FDA Approves Toripalimab for Nasopharyngeal Carcinoma - Medscape

Added to Collection on: 2023-10-30 21:44:14

Tags for this article:

Orphan drugs
Antineoplastic drugs
Breakthrough therapy
Cancer treatments
Cancer immunotherapy
Chemotherapy
Pembrolizumab
Atezolizumab
Coherus BioSciences
Gemcitabine
Cisplatin

Click the tags to see associated articles and topics

View Article Details
Coherus Oncology (CHRS) Projected to Post Earnings on Thursday - Defense World

Added to Collection on: 2025-08-02 12:53:27

Tags for this article:

Investment
Coherus BioSciences

Click the tags to see associated articles and topics

View Article Details
Book a Demo